AI-Driven Volume Responsiveness System with Integrated Technologies

Publication ID: 24-11857302_0008_PTD
Published: November 07, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “AI-Driven Volume Responsiveness System with Integrated Technologies,” Published Technical Disclosure No. 24-11857302_0008_PTD, Published November 07, 2025, available at https://archive.pr1or.art/24-11857302_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,302.

Summary of the Inventive Concept

A novel system integrating AI, IoT, blockchain, and nanomaterials to determine a patient's volume responsiveness, providing a more accurate and efficient fluid management approach.

Background and Problem Solved

The original patent's method for determining volume responsiveness relied solely on oscillometric non-invasive pulse measurements. However, this approach has limitations in terms of accuracy and real-time monitoring. The new inventive concept addresses these limitations by synergistically combining the patented method with advanced technologies, enabling a more comprehensive and effective fluid management system.

Detailed Description of the Inventive Concept

The AI-Driven Volume Responsiveness System comprises a wearable device equipped with nanomaterial-based sensors for measuring pulse signals. The signals are transmitted to an AI-powered processor, which analyzes the data using machine learning algorithms and generates a volume responsiveness indicator. The indicator is then stored in a cloud-based storage or blockchain-based decentralized storage, providing secure and accessible health records. Healthcare professionals can access the indicator through a user-friendly interface, enabling informed fluid management decisions. Additionally, IoT-enabled sensors can be integrated to enhance real-time monitoring and analysis.

Novelty and Inventive Step

The new claims introduce the novel combination of AI, IoT, blockchain, and nanomaterials with the original patented method, providing a synergistic improvement in accuracy, efficiency, and real-time monitoring. This integration enables a more comprehensive and effective fluid management system, which is not obvious from the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include the use of different AI algorithms, integration with other health monitoring devices, or implementation in various healthcare settings. Variations of the system could also include the use of different types of sensors or data analysis techniques.

Potential Commercial Applications and Market

The AI-Driven Volume Responsiveness System has significant commercial potential in the healthcare industry, particularly in critical care and emergency medicine. The system's ability to provide accurate and real-time volume responsiveness indicators can improve patient outcomes, reduce healthcare costs, and enhance the overall quality of care.

Field of Art

Medical Diagnostics and Patient Monitoring Systems, with expertise in physiological signal processing, medical sensor technologies, and data analysis techniques for patient volume responsiveness assessment

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical technology specialist with advanced knowledge of signal processing, machine learning, sensor technologies, and healthcare data management systems, holding advanced degrees and practical experience in medical device development

Obviousness Rationale

A person having ordinary skill in the art would recognize that integrating AI, IoT, and blockchain technologies with the existing volume responsiveness measurement method represents a predictable application of known technological solutions to enhance medical data collection and analysis. The fundamental approach of measuring patient pulse signals remains consistent with the source patent, while the proposed variations merely introduce standard technological improvements in data processing and storage. These modifications would be considered routine optimization and combination of known techniques within the medical technology domain.

Obvious Combinations & Variations

Source Patent Element
Oscillometric non-invasive pulse measurement method for determining patient volume responsiveness
PTD Variation
Integration of nanomaterial-based sensors for pulse signal measurement
Obviousness Reasoning
Sensor technology evolution is a predictable progression, and replacing traditional sensors with nanomaterial-based alternatives would be an obvious design choice for improving signal precision and miniaturization
Source Patent Element
Patient pulse signal analysis using mathematical signal processing techniques
PTD Variation
Implementing machine learning algorithms for signal analysis and volume responsiveness indicator generation
Obviousness Reasoning
Applying machine learning to medical signal processing is a known technique for enhancing diagnostic accuracy, representing a standard technological improvement that would be obvious to a skilled practitioner
Source Patent Element
Method for generating volume responsiveness indicators based on patient physiological signals
PTD Variation
Cloud-based and blockchain-based storage and access of patient volume responsiveness data
Obviousness Reasoning
Implementing secure, distributed data storage technologies is a standard approach for managing medical records, representing a predictable solution for improving data management and accessibility
Source Patent Element
Patient pulse signal measurement across respiratory cycles
PTD Variation
IoT-enabled real-time monitoring and continuous data transmission
Obviousness Reasoning
Extending signal measurement to continuous, networked monitoring is a logical and obvious technological progression in medical device design
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. § 103, the variations disclosed in this technical publication would be considered obvious extensions of US Patent 11857302, as they represent predictable combinations of known medical technology techniques that would be readily apparent to a person having ordinary skill in the art of medical diagnostic systems and signal processing. The proposed innovations constitute routine technological improvements that do not rise to the level of non-obvious invention.

Original Patent Information

Patent NumberUS 11,857,302
TitleMethod, logic unit and system for determining a parameter representative for the patient's volume responsiveness
Assignee(s)PHILIPS MEDIZIN SYSTEME BÖBLINGEN GMBH